6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
12m ago	Kraft Heinz Announces Pricing Terms and the Accepted Tender Amounts for the Cash Tender Offer for Up To $1.1 Billion Aggregate Purchase Price of Certain of Its Outstanding Notes
12m ago	L.B. Foster Company Announces the Appointment of Executive Officers
12m ago	Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants
12m ago	DRC Gold Corp. Amends Binding Term Sheet and Issues 25m Shares Pursuant to Option to Acquire Interests in Giro and Nizi Gold Projects
12m ago	Guggenheim Investments Appoints Robert Camacho as Chief Strategy Officer

About

5.53USD-0.00 -0.09%

Closed • Updated at 18:48 GMT+00:00

Market Cap$82.78M

Volume82.2K

Beta0.76

RSI72.67

Gross Margin72.42%

Health TechnologyPharmaceuticals: Major

Cumberland Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex

CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE

Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting

Community Chat

Ask AI